Design of high‐monounsaturated fatty acid soybean seed oil using GmPDCTs knockout via a CRISPR‐Cas9 system
Plant Biotechnology Journal · 2023
DOI: 10.1111/pbi.14060 ↗Kurz gefasst
Fachartikel in der Zeitschrift Plant Biotechnology Journal, 2023. Verfasst von Haibo Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of Smart Farm Technology and System, Key Laboratory of Soybean Biology in Chinese Education Ministry, Northeast Agricultural …. Hauptthemen laut MEDLINE: Glycine max, CRISPR-Cas Systems. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Key Laboratory of Smart Farm Technology and System, Key Laboratory of Soybean Biology in Chinese Education Ministry, Northeast Agricultural University, Harbin, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, H., Zhou, R., Liu, P., Yang, M., Xin, D., Liu, C., Zhang, Z., Wu, X., Chen, Q., & Zhao, Y. (2023). Design of high‐monounsaturated fatty acid soybean seed oil using GmPDCTs knockout via a CRISPR‐Cas9 system. Plant Biotechnology Journal. https://doi.org/10.1111/pbi.14060
Vancouver
Li H, Zhou R, Liu P, Yang M, Xin D, Liu C, et al. Design of high‐monounsaturated fatty acid soybean seed oil using GmPDCTs knockout via a CRISPR‐Cas9 system. Plant Biotechnology Journal. 2023. doi:10.1111/pbi.14060
BibTeX
@article{Li2023,
author = {Li, Haibo and Zhou, Runnan and Liu, Peiyan and Yang, Mingliang and Xin, Dawei and Liu, Chunyan and Zhang, Zhanguo and Wu, Xiaoxia and Chen, Qingshan and Zhao, Ying},
title = {Design of high‐monounsaturated fatty acid soybean seed oil using GmPDCTs knockout via a CRISPR‐Cas9 system},
journal = {Plant Biotechnology Journal},
year = {2023},
doi = {10.1111/pbi.14060}
}
EUVIMED